Cullen Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $491K | Sell |
2,342
-1,430
| -38% | -$300K | 0.01% | 156 |
|
|
2024
Q4 | $670K | Hold |
3,772
| – | – | 0.01% | 164 |
|
|
2024
Q3 | $745K | Hold |
3,772
| – | – | 0.01% | 141 |
|
|
2024
Q2 | $647K | Hold |
3,772
| – | – | 0.01% | 135 |
|
|
2024
Q1 | $687K | Buy |
3,772
+298
| +9% | +$54.3K | 0.01% | 127 |
|
|
2023
Q4 | $538K | Buy |
3,474
+234
| +7% | +$36.3K | 0.01% | 155 |
|
|
2023
Q3 | $483K | Sell |
3,240
-192
| -6% | -$28.6K | 0.01% | 140 |
|
|
2023
Q2 | $462K | Hold |
3,432
| – | – | ﹤0.01% | 234 |
|
|
2023
Q1 | $547K | Sell |
3,432
-88
| -3% | -$14K | 0.01% | 202 |
|
|
2022
Q4 | $569K | Hold |
3,520
| – | – | 0.01% | 154 |
|
|
2022
Q3 | $472K | Buy |
3,520
+280
| +9% | +$37.5K | 0.01% | 220 |
|
|
2022
Q2 | $496K | Hold |
3,240
| – | – | 0.01% | 219 |
|
|
2022
Q1 | $525K | Sell |
3,240
-369
| -10% | -$59.8K | ﹤0.01% | 216 |
|
|
2021
Q4 | $489K | Buy |
+3,609
| New | +$489K | ﹤0.01% | 232 |
|
|
2021
Q3 | – | Sell |
-3,525
| Closed | -$397K | – | 270 |
|
|
2021
Q2 | $397K | Buy |
3,525
+9
| +0.3% | +$1.01K | ﹤0.01% | 226 |
|
|
2021
Q1 | $381K | Buy |
+3,516
| New | +$381K | ﹤0.01% | 228 |
|